PolarCool AB (publ) (98H0) - Net Assets
Based on the latest financial reports, PolarCool AB (publ) (98H0) has net assets worth €7.04 Million EUR as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€10.79 Million) and total liabilities (€3.75 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €7.04 Million |
| % of Total Assets | 65.24% |
| Annual Growth Rate | -1.83% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 104.43 |
PolarCool AB (publ) - Net Assets Trend (2021–2024)
This chart illustrates how PolarCool AB (publ)'s net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PolarCool AB (publ) (2021–2024)
The table below shows the annual net assets of PolarCool AB (publ) from 2021 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €12.47 Million | +179.99% |
| 2023-12-31 | €4.45 Million | -25.97% |
| 2022-12-31 | €6.01 Million | -54.36% |
| 2021-12-31 | €13.18 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PolarCool AB (publ)'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 1969223000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | €59.81 Million | 479.71% |
| Total Equity | €12.47 Million | 100.00% |
PolarCool AB (publ) Competitors by Market Cap
The table below lists competitors of PolarCool AB (publ) ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Svenska Aerogel Holding AB (publ)
ST:AERO
|
$4.33 Million |
|
PMPG Polskie Media S.A.
WAR:PGM
|
$4.33 Million |
|
MOVIE GAMES S.A. ZY1
F:2LH
|
$4.33 Million |
|
GSS Infotech Limited
NSE:GSS
|
$4.33 Million |
|
Gungnir Resources Inc
V:GUG
|
$4.33 Million |
|
NEOLIFE EO -10
F:8JB
|
$4.33 Million |
|
Foresight Solar Fund Ltd
LSE:FSFL
|
$4.32 Million |
|
K9 Gold Corp
V:KNC
|
$4.32 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PolarCool AB (publ)'s equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,453,020 to 12,467,936, a change of 8,014,916 (180.0%).
- Net loss of 11,024,542 reduced equity.
- New share issuances of 19,039,457 increased equity.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €-11.02 Million | -88.42% |
| Share Issuances | €19.04 Million | +152.71% |
| Other Changes | €1.00 | +0.0% |
| Total Change | €- | 179.99% |
Book Value vs Market Value Analysis
This analysis compares PolarCool AB (publ)'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.13x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has increased from 0.00x to 0.13x over the analyzed period, suggesting growing market confidence.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | €73.67 | €0.34 | x |
| 2022-12-31 | €27.80 | €0.34 | x |
| 2023-12-31 | €5.33 | €0.34 | x |
| 2024-12-31 | €2.67 | €0.34 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PolarCool AB (publ) utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -88.42%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -529.24%
- • Asset Turnover: 0.14x
- • Equity Multiplier: 1.22x
- Recent ROE (-88.42%) is above the historical average (-154.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -53.89% | -951.72% | 0.04x | 1.28x | €-8.42 Million |
| 2022 | -202.74% | -640.57% | 0.16x | 1.97x | €-12.80 Million |
| 2023 | -271.86% | -881.62% | 0.14x | 2.25x | €-12.55 Million |
| 2024 | -88.42% | -529.24% | 0.14x | 1.22x | €-12.27 Million |
Industry Comparison
This section compares PolarCool AB (publ)'s net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $32,773,339,810
- Average return on equity (ROE) among peers: -13.82%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PolarCool AB (publ) (98H0) | €7.04 Million | -53.89% | 0.53x | $4.33 Million |
| Sysmex Corporation (0YX) | $188.09 Billion | 19.26% | 0.42x | $4.84 Billion |
| HeraMED Limited (1I4) | $6.15 Million | -86.78% | 0.27x | $26.40 Million |
| MAUNA KEA TECHNOL.EO -04 (1MK) | $-10.33 Million | 0.00% | 0.00x | $32.08 Million |
| INFUSYSTEMS HLDG.DL-0001 (1TZ) | $57.33 Million | 11.56% | 0.75x | $167.65 Million |
| PHC HOLDINGS CORP. (2GY) | $139.16 Billion | -9.26% | 3.06x | $740.08 Million |
| Q-linea AB (publ) (3F80) | $430.45 Million | -53.77% | 0.13x | $39.79 Million |
| Guerbet SA (4G8) | $314.80 Million | 9.19% | 2.27x | $133.92 Million |
| Peijia Medical Limited (4WO) | $-558.21 Million | 0.00% | 0.00x | $403.65 Million |
| ENVVENO MEDICAL DL-00001 (5HJ) | $42.16 Million | -51.75% | 0.07x | $196.50K |
| GENTIAN DIAGNOST. NO -01 (6FK) | $194.05 Million | 23.34% | 0.18x | $54.58 Million |
About PolarCool AB (publ)
PolarCool AB (publ), a medical device company, develops, markets, and sells products for sports medicine. The company provides PolarCap System, a portable cooling device for the treatment of concussive and sub-concussive brain injury. It serves teams, organizations, and athletes. PolarCool AB (publ) was incorporated in 2017 and is based in Lund, Sweden.